Trial Profile
Measles-mumps-rubella vaccine at 6 months of age, immunology, and childhood morbidity in a high-income setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jan 2022
Price :
$35
*
At a glance
- Drugs Measles mumps and rubella virus vaccine (Primary) ; Measles mumps and rubella virus vaccine (Primary)
- Indications Measles; Mumps; Rubella
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms The 6 months MMR Trial
- 28 Jan 2022 Status changed from recruiting to completed.
- 17 Feb 2017 New trial record